In this study, the capsid protein coding region of serotype Asia-1 viruses (n=131) were analyzed, giving importance to the viruses circulating since 2011 within the Group VII (Sind-08). The isolates recovered during 2011-2017 were found to group within the re-emerging cluster of Group VII (Sind-08). The time of the most recent common ancestor for this cluster was estimated to be approximately 2004. In comparison to the older isolates of Group VII (2001-2004), the re-emerging viruses showed variation at fourteen amino acid positions, including substitutions at the antigenically critical residues VP1140, VP1142 and VP277. In Group VII (Sind-08), all three major antigenic sites have mutations (Site I and II had four consensus changes at positions 140, 141 and 77, 79 respectively, while site IV had a replacement at position 59) relative to the internationally recommended vaccine strain (Shamir 89). This study also explains the development and optimization of a new RT-PCR method that may be employed to amplify and sequence a 2901 base pair (bp) section covering entire capsid coding region (P1) of the FMDV genome. This method offers a tool that can be employed for antigenic profiling and phylogenetic analyses of FMDV to help vaccine matching or strain selection in the episode of outbreaks.
Bu çalışmada, 2011’den bu güne kadar Grup VII (Sind-08) içerinde yer alarak dolaşan virüslere vurgu yapılmak suretiyle serotip Asya1 virüslerinin (n=131) kapsid proteinini kodlayan bölgesi analiz edildi. 2011-2017 yılları süresince elde edilen izolatların Grup VII (Sind-08)’nin yeniden çıkış gösteren topluluğu içerisinde gruplandığı tespit edildi. Bu topluluk için en güncel ortak atanın zamanı, yaklaşık 2004 olarak tahmin edildi. Grup VII (2001-2004)’nin eski izolatları ile karşılaştırıldığında, yeniden çıkış gösteren virüsler on dördüncü amino asit pozisyonunda antijenik olarak önemli rezidüler olan VP1140, VP1142 ve VP277’de yer değiştirmeleri içeren varyasyonlar göstermekteydi. Uluslararası tavsiye edilen aşı suşları (Shamir 89) ile karşılaştırıldığında, Grup VII (Sind-08)’de tüm üç majör antijenik bölgede (Bölge I ve II’de sırasıyla 140, 141 ve 77, 79 pozisyonlarında dört konsensüs değişiklik ve bölge IV’de pozisyon 59’da yer değiştirme) mutasyon bulunmaktaydı. Bu çalışma ile Şap Hastalığı Virüsü genomunun tüm kapsid kodlayan bölgesini (P1) içeren 2901 baz çifti bölgesini amlifiye etme ve sekanslamada yeni bir RTPCR metodunun geliştirilmesi ve optimizasyonu açıklanmıştır. Bu metot, salgınlarda aşı eşleştirme veya suş seçimine yardım etmek için Şap Hastalığı Virüsünün antijenik profili ve filogenetik analizi amacıyla kullanılabilir.
___
Fleige S, Pfaffl MW: RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med, 27 (2-3): 126-139, 2006. DOI: 10.1016/j.mam.2005.12.003
Ibarbalz FM, Pérez MV, Figuerola EL, Erijman L: The bias associated with amplicon sequencing does not affect the quantitative assessment of bacterial community dynamics. PLoS One, 9 (6): e99722, 2014. DOI: 10.1371/journal.pone.0099722
Knowles NJ, Samuel AR: Molecular epidemiology of foot-andmouth disease virus. Virus Res, 91 (1): 65-80, 2003. DOI: 10.1016/S0168- 1702(02)00260-5
Vangrysperre W, De Clercq K: Rapid and sensitive polymerase chain reaction based detection and typing of foot-and-mouth disease virus in clinical samples and cell culture isolates, combined with a simultaneous differentiation with other genomically and/or symptomatically related viruses. Arch Virol, 141 (2): 331-344, 1996. DOI: 10.1007/BF01718403
Reeve R, Blignaut B, Esterhuysen JJ, Opperman P, Matthews L, Fry EE, de Beer TA, Theron J, Rieder E, Vosloo W, O’Neill HG, Haydon DT, Maree FF: Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus. PLoS Comput Biol, 6 (12): e1001027, 2010. DOI: 10.1371/journal. pcbi.1001027
Pacheco JM, Brum MCS, Moraes MP, Golde WT, Grubman MJ: Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology, 337 (2): 205-209, 2005. DOI: 10.1016/j. virol.2005.04.014
Yang M, Clavijo A, Suarez-Banmann R, Avalo R: Production and characterization of two serotype independent monoclonal antibodies against foot-and-mouth disease virus. Vet Immunol Immunopathol, 115 (1-2): 126-134, 2007. DOI: 10.1016/j.vetimm.2006.10.002
Balamurugan V, Renji R, Saha SN, Reddy GR, Gopalakrishna S, Suryanarayana VVS: Protective immune response of the capsid precursor polypeptide (P1) of foot and mouth disease virus type ‘O’produced in Pichia pastoris. Virus Res, 92 (2): 141-149, 2003. DOI: 10.1016/S0168-1702(02)00357-X
Cottam EM, Haydon DT, Paton DJ, Gloster J, Wilesmith JW, Ferris NP, Hutchings GH, King DP: Molecular epidemiology of the foot-andmouth disease virus outbreak in the United Kingdom in 2001. J Virol, 80 (22): 11274-11282, 2006. DOI: 10.1128/JVI.01236-06
Brito BP, Rodriguez LL, Hammond JM, Pinto J, Perez AM: Review of the global distribution of foot-and-mouth disease virus from 2007 to 2014. Transbound Emerg Dis, 64 (2): 316-332, 2017. DOI: 10.1111/ tbed.12373
Jamal SM, Ferrari G, Ahmed S, Normann P, Curry S, Belsham GJ: Evolutionary analysis of serotype A foot-and-mouth disease viruses circulating in Pakistan and Afghanistan during 2002-2009. J Gen Virol, 92, 2849-2864, 2011. DOI: 10.1099/vir.0.035626-0
Schumann KR, Knowles NJ, Davies PR, Midgley RJ, Valarcher JF, Raoufi AQ, McKenna TS, Hurtle W, Burans JP, Martin BM, Rodriguez LL, Beckham TR: Genetic characterization and molecular epidemiology of foot-and-mouth disease viruses isolated from Afghanistan in 2003 -2005. Virus Genes, 36 (2): 401-413, 2008. DOI: 10.1007/s11262-008-0206-4
Sumption K, Rweyemamu M, Wint W: Incidence and distribution of foot-and-mouth disease in Asia, Africa and South America; combining expert opinion, official disease information and livestock populations to assist risk assessment. Transbound Emerg Dis, 55 (1): 5-13, 2008. DOI:10.1111/j.1865-1682.2007.01017.x
Knight-Jones TJ, Robinson L, Charleston B, Rodriguez LL, Gay CG, Sumption KJ, Vosloo W: Global foot-and-mouth disease research update and gap analysis: 4-Diagnostics. Transbound Emerg Dis, 63 (Suppl 1): 42-48, 2016. DOI: 10.1111/tbed.12523
Waheed U, Parida S, Khan QM, Hussain M, Ebert K, Wadsworth J, Reid SM, Hutchings GH, Mahapatra M, King D, Paton DJ, Knowles NJ: Molecular characterisation of foot-and-mouth disease viruses from Pakistan, 2005-2008. Transbound Emerg Dis, 58 (2): 166-172, 2011. DOI: 10.1111/j.1865-1682.2010.01186.x
Jamal SM, Ferrari G, Ahmed S, Normann P, Belsham GJ: Genetic diversity of foot-and-mouth disease virus serotype O in Pakistan and Afghanistan, 1997-2009. Infect Genet Evol, 11 (6): 1229-1238, 2011. DOI: 10.1016/j.meegid.2011.03.006
Subramaniam S, Bisht P, Mohapatra J, Sanyal A, Pattnaik B: A new lineage of foot-and-mouth disease virus serotype O in India. Vet Ital, 51 (2): 145-149, 2015. DOI: 10.12834/VetIt.106.296.2
Zhang Q, Liu X, Fang Y, Pan L, Lv J, Zhang Z, Zhou P, Ding Y, Chen H, Shao J, Zhao F, Lin T, Chang H, Zhang J, Wang Y, Zhang Y: Evolutionary analysis of structural protein gene VP1 of foot-and-mouth disease virus serotype Asia 1. Scientific World Journal, 2015: 734253. DOI: 10.1155/2015/734253
Ullah A, Jamal SM, Romey A, Gorna K, Kakar MA, Abbas F, Ahmad J, Zientara S, Bakkali Kassimi L: Genetic characterization of serotypes A and Asia-1 foot-and-mouth disease viruses in Balochistan, Pakistan, in 2011. Transbound Emerg Dis, 64 (5): 1569-1578, 2017. DOI: 10.1111/ tbed.12548
Jamal SM, Ferrari G, Ahmed S, Normann P, Belsham GJ: Molecular characterization of serotype Asia-1 foot-and-mouth disease viruses in Pakistan and Afghanistan; emergence of a new genetic Group and evidence for a novel recombinant virus. Infect Genet Evol, 11 (8): 2049- 2062, 2011. DOI: 10.1016/j.meegid.2011.09.015
Valarcher JF, Knowles NJ, Ferris NP, Paton DJ, Zakharov V, Sherbakov A, Shang YJ, Liu ZX, Liu X, Sanyal A, Hemadri D, Tosh C, Rasool TJ: Recent spread of FMD virus serotype Asia 1. Vet Rec, 157 (1): 30, 2005. DOI: 10.1136/vr.157.1.30
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S: MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol Biol Evol, 30 (12): 2725-2729, 2013. DOI: 10.1093/molbev/mst197
BLAST. https://blast.ncbi.nlm.nih.gov/Blast.cgi; Accessed: 06.02.2017.
Sanger F, Nicklen S, Coulson AR: DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sci U S A, 74 (12): 5463-5467, 1977.
Ali W, Habib M, Sajid S, Khan RSA, Mazhar MU, Khan IU, Saliha U, Farooq M, Shah MSUD, Muzammil HM: A reverse transcriptionpolymerase chain reaction (RT-PCR) based detection of foot-and-mouth disease in district Faisalabad, Pakistan during the year 2016. Matrix Science Medica, 1 (1): 27-29, 2017. DOI: 10.26480/msm.01.2017.27.29
Ali W, Habib M, Khan RSA, Zia MA, Khan IU, Saliha U, Farooq M, Shah MS, Muzammil HM: Reverse transcription-polymerase chain reaction (RT-PCR) based detection and economic impact of foot-andmouth disease in district Faisalabad, Pakistan during the year 2015. Iraqi J Vet Sci, 31 (1): 1-6, 2017.
GenBank: https://www.ncbi.nlm.nih.gov/genbank/; Accessed: 01.03.2017.
Anonymous: WRLFMD Quarterly Report, July to September 2016, Reference Laboratory Contract Report., 2016.
Mateu MG: Antibody recognition of picornaviruses and escape from neutralization: A structural view. Virus Res, 38 (1): 1-24, 1995. DOI: 10.1016/0168-1702(95)00048-U
Grazioli S, Fallacara F, Brocchi E: Mapping of antigenic sites of footand-mouth disease virus serotype Asia 1 and relationships with sites described in other serotypes. J Gen Virol, 94, 559-569, 2013. DOI: 10.1099/ vir.0.048249-0
Mateu MG, Martinez MA, Capucci L, Andreu D, Giralt E, Sobrino F, Brocchi E, Domingo E: A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-andmouth disease virus of serotype C. J Gen Virol, 71, 629-637, 1990. DOI: 10.1099/0022-1317-71-3-629
Lea S, Hernéndez J, Blakemore W, Brocchi E, Curry S, Domingo E, Fry E, Abu-Ghazaleh R, King A, Newman J, Stuart D, Mateu MG: The structure and antigenicity of a type C foot-and-mouth disease virus. Structure, 2 (2): 123-139, 1994. DOI: 10.1016/S0969-2126(00)00014-9
Mahapatra M, Seki C, Upadhyaya S, Barnett PV, La Torre J, Paton DJ: Characterisation and epitope mapping of neutralising monoclonal antibodies to A24 Cruzeiro strain of FMDV. Vet Microbiol, 149 (1-2): 242- 247, 2011. DOI: 10.1016/j.vetmic.2010.11.003
Bolwell C, Clarke BE, Parry NR, Ouldridge EJ, Brown F, Rowlands DJ: Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. J Gen Virol, 70, 59-68, 1989. DOI: 10.1099/0022- 1317-70-1-59
Baxt B, Vakharia V, Moore DM, Franke AJ, Morgan DO: Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol, 63 (5): 2143-2151, 1989.
Thomas AA, Woortmeijer RJ, Puijk W, Barteling SJ: Antigenic sites on foot-and-mouth disease virus type A10. J Virol, 62 (8): 2782-2789, 1988.
Aktas S, Samuel AR: Identification of antigenic epitopes on the foot and mouth disease virus isolate O1/Manisa/Turkey/69 using monoclonal antibodies. Rev Sci Tech, 19 (3): 744-753, 2000.
Kitson JDA, McCahon D, Belsham GJ: Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: Evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology, 179 (1): 26-34, 1990. DOI: 10.1016/0042-6822(90)90269-W
Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F, Parry NR: Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J Gen Virol, 70, 1483-1491, 1989. DOI: 10.1099/0022- 1317-70-6-1483
Pfaff E, Thiel HJ, Beck E, Strohmaier K, Schaller H: Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Virol, 62 (6): 2033-2040, 1988.
Xie QC, McCahon D, Crowther JR, Belsham GJ, McCullough K: Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol, 68, 1637-1647, 1987. DOI: 10.1099/0022-1317-68-6-1637
Sobrino F, Domingo E: Foot-and-mouth disease in Europe. EMBO Rep, 2 (6): 459-461, 2001. DOI: 10.1093/embo-reports/kve122
Samuel AR, Knowles NJ: Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol, 82, 609-621, 2001. DOI: 10.1099/0022-1317-82- 3-609
Fry EE, Stuart DI, Rowlands DJ: The structure of foot-and-mouth disease virus. Curr Top Microbiol Immunol, 288, 71-101, 2005. DOI: 10.1007/3-540-27109-0_4
Valdazo-Gonzalez B, Kim JT, Soubeyrand S, Wadsworth J, Knowles NJ, Haydon DT, King DP: The impact of within-herd genetic variation upon inferred transmission trees for foot-and-mouth disease virus. Infect Genet Evol, 32, 440-448, 2015. DOI: 10.1016/j.meegid.2015.03.032
Brito BP, Perez AM, Jamal SM, Belsham GJ, Pauszek SJ, Ahmed Z, Rodriguez LL: Foot-and-mouth disease virus serotype O phylodynamics: Genetic variability associated with epidemiological factors in Pakistan. Transbound Emerg Dis, 60 (6): 516-524, 2013. DOI: 10.1111/j.1865- 1682.2012.01366.x
Jamal SM, Ferrari G, Hussain M, Nawroz AH, Aslami AA, Khan E, Murvatulloev S, Ahmed S, Belsham GJ: Detection and genetic characterization of foot-and-mouth disease viruses in samples from clinically healthy animals in endemic settings. Transbound Emerg Dis, 59 (5): 429-440, 2012. DOI: 10.1111/j.1865-1682.2011.01295.x
Drake JW, Holland JJ: Mutation rates among RNA viruses. Proc Natl Acad Sci U S A, 96 (24): 13910-13913, 1999.
Jamal SM, Ahmed S, Hussain M, Ali Q: Status of foot-and-mouth disease in Pakistan. Arch Virol, 155 (9): 1487-1491, 2010. DOI: 10.1007/ s00705-010-0732-y
Bozukluhan K, Atakisi E, Atakisi O: Nitric oxide levels, total antioxidant and oxidant capacity in cattle with foot-and-mouth-disease. Kafkas Univ Vet Fak Derg, 19 (1): 179-181, 2013. DOI: 10.9775/kvfd.2012.7244
Uzlu E, Karapehlivan M, Erdogan HM, Kızıltepe S, Erkılıc EE, Deveci HA, Gokce E, Kaya I, Citil M: Serum and saliva sialic acid and oxidative stress parameters changes in bulls with foot and mouth disease. Kafkas Univ Vet Fak Derg, 22 (3): 321-325, 2016. DOI: 10.9775/kvfd.2015.13114
Elitok B, Balıkcı E, Kececi H, Yılmaz K: Creatinin phosphokinase (CPK), lactate dehydrogenase (LDH), aspartat aminotransferase (AST) activities, glucose levels and ECG findings in cattle with foot and mouth disease. Kafkas Univ Vet Fak Derg, 5 (2): 161-166, 1999.
Mason PW, Grubman MJ, Baxt B: Molecular basis of pathogenesis of FMDV. Virus Res, 91 (1): 9-32, 2003. DOI: 10.1016/S0168-1702(02)00257-5